1-2 of 2
Scarlet Musiol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Remission to Imatinib in Patients with Chronic Myeloid Leukaemia (CML) Is Less Durable Compared to Patients after Allografting.

Thoralf Lange, MD, Thomas Bumm, Marc Mueller, Sandra Otto, Haifa K. Al-Ali, MD, Leanthe Grommisch, MD, Scarlet Musiol, Christina Franke, Rainer Krahl, PHD, Dietger W. Niederwieser, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 276.
https://doi.org/10.1182/blood.V104.11.276.276
Published: 2004
Journal Articles

High levels of BAX , low levels of MRP-1 , and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML

Clinical Trials & Observations Brief Report
Thoralf Lange, Christine Günther, Thomas Köhler, Rainer Krahl, Scarlet Musiol, Sabine Leiblein, Haifa-Kathrin Al-Ali, Iris van Hoomissen, Dietger Niederwieser, Michael W. N. Deininger
Journal: Blood
Blood (2003) 101 (6): 2152–2155.
https://doi.org/10.1182/blood-2002-05-1366
Published: 2003